featured
Clinical and Safety Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Use in Patients With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Clinical Endocrinology and Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical and Safety Outcomes with GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study
J. Clin. Endocrinol. Metab. 2022 Oct 21;[EPub Ahead of Print], K Edwards, X Li, I LingvayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.